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Abstract
Adolescents and young adults remain underrepresented in clinical trials. Knowledge and
perceptions related to clinical research usually determine willingness to participate. During
the spring of 2016, an in-class paper survey was conducted to determine whether providing a
brief introduction to clinical research would affect the willingness of undergraduate students
from the College of Arts and Sciences and the College of Technology at Eastern Michigan
University to participate in clinical trials. Some participants received information on clinical
research through a short paragraph, and some received no new information, which
differentiated the “active” group from the “placebo” group. Overall, both groups provided
similar responses to the questions related to understanding and willingness. The majority (>
40%) of responders answered that they had little knowledge. However, only 37% of the
active group and 11% of placebo group participants knew that the research was related to
humans. Across both groups, nearly 60% of responders expressed willingness to participate
in clinical trials. Monetary compensation was the most common motivator, and uncertainty
about safety was the most common reason for non-participation in clinical trials.
Keywords: clinical trials, participation, willingness
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Chapter 1: Introduction
According to the World Health Organization, “A clinical trial is any research study
that prospectively assigns human participants or groups of humans to one or more healthrelated interventions to evaluate the effects on health outcomes.” Clinical trials (CTs) play a
significant role in the advancement of medicine by enhancing the approachability of various
treatments. Along with a rising population, there is an equivalent increase in the incidence of
various diseases. However, considering the uncertainty of the outcomes, people’s resistance
to taking part in clinical studies has been growing. While a few participate, many others step
back, being skeptical of the unexpected effects of a new molecular entity. Spreading
awareness is the only way to improve participation (Bevan, Chee, McGhee, & McInnes,
1993).
According to the Pharmaceutical Research and Manufacturers of America (PhRMA)
Annual Membership Survey (2016), approximately 48% of research and development
expenditure is related to conducting Phase I–III clinical trials. Recruitment issues are critical,
and a recently published whitepaper from Clinithink (2017) reported that 46% of trials fail
because of poor recruitments. In addition, recruitment delays significantly increase the
clinical trial budgets, currently about $1.3 million per delayed day. Nearly one-third of
clinical trial expenses are related to patient recruitment. The cost of patient recruitment
amounts to worldwide expenditures of $1.2 billion, $759 million in the US alone. During the
last decade, there was an increase of approximately 150% in eligibility criteria. Thus,
limitations in volunteer participation results in clinical trials getting costly and delayed, and
failing to address the primary research question. The latest survey by the Center for
Information and Study on Clinical Research (CISCRP, 2017), taken by 12,427 people across
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the world, revealed that 87% of respondents were willing to participate in clinical trials. This
survey also reported that young people are generally less knowledgeable and less likely to
understand that clinical trials are safe. Perhaps for this reason they were also less willing to
participate (CISCRP, 2017). Data from the 2013 CISCRP survey regarding age were
analyzed by Nelson, Martin, and Getz, who observed that generational differences existed in
the perceptions on clinical trials and that the then 18 to 34-year-olds were the least willing to
participate in trials. These respondents were broadly referred to as Generation Y, and they
were found to be significantly less willing to participate in a trial than those aged 35 years or
older (Nelson et al., 2015).
Because adolescents and young people are underrepresented in several trials, this
hampers the availability of these treatments for these populations (Kapogiannis, 2008; Roth
et al., 2016; Brown et al., 2015). Reasons for participation and non-participation among
adolescents and young people have been studied by a multitude of researchers. However,
most of these studies were conducted in specific disease or racial groups (Ferrari, Montello,
Budd, & Bleyer, 2008; Cavallo, 2016; Parsons, Harlan, Seibel, Stevens, & Keegan, 2011;
Midgley, Isaacs, Weitkamp, & Target, 2016; Diaz, Mainous, McCall, & Geesey, 2008;
Pearce et al., 2016). Such data are lacking from healthy volunteers, who constitute a potential
pool of participants for future clinical trials.
Attitude and knowledge about clinical trials are the key factors that influence
willingness to participate. Early adulthood is a key phase of attitude formation. A positive
attitude inculcated towards clinical trial participation during this period is more likely to
promote participation in eligible trials (Visser, & Krosnick, 1998; Fishbein, & Ajzen, 1975).
In a recent survey by Brown et al. (2015) which evaluated knowledge and attitudes of
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adolescents towards clinical trials, only 33% of adolescents indicated that they had ever
heard of a clinical trial. Only a median of 46% of answers were correct, thus highlighting the
poor knowledge levels of this group on this topic. Educational interventions are therefore of
utmost importance to overcome the knowledge-related participation barriers among
adolescents (Brown et al., 2015).
During the winter of 2015, an email survey was conducted among the students
enrolled at Eastern Michigan University (EMU) to assess their knowledge on the most
commonly used terminology in an informed consent form. Of the approximately 20,000
recipients, only 1,869 responded, and only 45.1% of the respondents correctly identified the
definition for the term clinical research. For the question Where do you think clinical
research studies are conducted? 47.2% indicated that they thought it was conducted in
hospitals, 70.9% in medical centers, 34.8% in clinics, 15.9% in a private physician’s office,
and 4.6% were not sure (Garapati, 2015). The present study attempted to further investigate
students’ understanding and willingness to participate in clinical research through an in-class
paper survey.
Purpose of the Study
Several previous studies in cancer populations reported that educational interventions
using 15-minute to 18-minute video presentations substantially changed patients’ attitudes
towards clinical trials and increased trial enrolment rates (Banda, Libin, Wang, & Swain,
2012; Du, Mood, Gadgeel, & Simon, 2008). But no such research was conducted among
healthy adolescents and young adults to examine the effect of educational interventions.
Hence, the purpose of the present study was to assess whether providing basic awareness of
clinical research via an introductory reading influenced the willingness of Generation Y
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students (age 18–34 years) to participate in clinical trials. Specific research questions of the
study follow.
Research Questions
•

Does a short description of clinical research improve participant knowledge
and willingness to participate in a clinical trial?

•

Is there an influence of age, gender, class year, or college major on an
individual’s willingness to participate in clinical trials?
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Chapter 2: Methods
Undergraduate students from the College of Arts and Sciences and the College of
Technology at EMU were asked to participate in this in-class paper survey during the spring
2016 semester. Approval was obtained from the University Human Subjects Review
Committee (UHSRC) of EMU (Appendices A and B) before conducting the study. After
getting permission from the two colleges, students were verbally informed of this survey.
Two different kinds of survey sheets were provided randomly: one with a short description of
clinical research, termed the “active” survey sheet (Appendix C), and another containing a
short description of standard scientific method definition, not specific to clinical research,
termed the “placebo” survey sheet (Appendix D). Respondents to the former sheet composed
the active group, and those who responded to the latter were the placebo group. Both sheets
included 12 questions. Some questions were related to demographics (such as age, sex, class
year, and college major), and others were aimed at understanding and attitudes towards
participation in clinical research. Students were asked to return the surveys; doing so was
considered consent for participation (Appendix E).
All the data collected were entered into Microsoft Excel and later analyzed using
Statistical Package for the Social Sciences (SPSS). Since the study variables were
categorical, they were presented as counts and percentages in the results tables. Data related
to each question were compared between the active and placebo groups to understand the
effect of this intervention on knowledge and perception of clinical trials. Chi-square tests
were performed to assess whether significant differences existed between the study groups
and to explore any possible impact of demographic variables on knowledge- or perceptionrelated responses.
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Chapter 3: Results
In total, 220 undergraduate students responded to this survey, of whom 106 were in
the active group and 114 were in the placebo group. Descriptive characteristics of the survey
participants are presented in Table 1.
Table 1
Demographics of Survey Respondents
Demographics
Age range
18–24 yrs
25–34 yrs
35 or older
Unspecified
Sex
Female
Male
Unspecified
College Year
First
Second
Third
Fourth
Graduate
College Major
Arts & Sciences
Technology

All Respondents
n (%)

Active Group
n (%)

Placebo Group
n (%)

155 (70.5%)
44 (20.0%)
20 (9.1%)
1 (0.5%)

73 (68.9%)
22 (20.8%)
10 (9.4%)
1 (0.9%)

82 (71.9%)
22 (19.3%)
10 (8.8%)
0 (0.0%)

78 (35.5%)
140 (63.6%)
2 (0.9%)

36 (34.0%)
69 (65.1%)
1 (0.9%)

42 (36.8%)
71 (62.3%)
1 (0.9%)

29 (13.2%)
40 (18.2%)
46 (20.9%)
103 (46.8%)
2 (0.9%)

16 (15.1%)
19 (17.9%)
24 (22.6%)
47 (44.3%)
0 (0.0%)

13 (11.4%)
21 (18.4%)
22 (19.3%)
56 (49.1%)
2 (1.8%)

111 (50.5%)
109 (49.5%)

53 (50.0%)
53(50.0%)

58 (50.9%)
56 (49.1%)

Survey Response Results by Intervention
The survey response results among the active and placebo respondents are presented
in Table 2. A similar percentage of active and placebo group respondents were found to have
complete, somewhat, little knowledge, and no knowledge at all on clinical trials with no
significant difference between the groups. Only 1% of active group and 4% of placebo group
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participants appeared to have complete knowledge on clinical trials. More than 40% of
respondents across both groups answered that they had little knowledge.
As an answer to the multiple-choice question on clinical trial/research definition, only
37% of the active group and 11% of placebo group participants knew that the research is
related to humans. Nearly half of the placebo group students thought clinical research related
to laboratory investigations. Although a slightly higher percentage of respondents in the
active group than in the placebo group answered the clinical trial definition question
correctly, the difference was not significant.
Across both study groups, 60% of participants expressed willingness to participate in
clinical trials, and there was no significant difference between the groups. Only 14% of the
active group and 15% of the placebo group respondents said yes to participation in clinical
trials with a novel treatment untested in animals or humans, indicating no difference between
the groups.
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Table 2
Difference in Survey Responses Between Active and Placebo Groups

Knowledge Levels
Complete
Somewhat
Little
No knowledge at all
Definition of Clinical
Research
Humans
Animals
Laboratory Studies
Humans and Animals
Humans and Lab Studies
Humans, Animals, and
Lab Studies
Not Sure
Correctness of Clinical Trial
Definition
Correct Response
Incorrect Response
Willingness to Participate
Yes
No
Willingness to Administer a
Novel Treatment
Yes
No
Preferred Mode of
Communication regarding a
Clinical Trial
From my Physician
Reading an advertisement
Government List
Campus Posting
Facebook or Other Social
Media

Active group, n (%)

Placebo Group, n (%)

1 (0.9%)
20 (18.9%)
49 (46.2%)
36 (34.0%)

4 (3.5%)
25 (21.9%)
49 (43.0%)
36 (31.6%)

χ2, p value
2.067, 0.559

8.767, 0.187
39 (36.8%)
31 (27.2%)
31 (29.2%)
2 (1.9%)
1 (0.9%)
3 (2.8%)

12 (11.3%)
7 (6.1%)
52 (45.6%)
1 (0.9%)
0 (0.0%)
4 (3.5%)

18 (17.0%)

19 (16.7%)
2.333, 0.127

39 (36.8%)
67 (63.2%)

31 (27.2%)
83 (72.8%)
0.231, 0.631

63 (60.0%)

72 (63.2%)

42 (40.0%)

42 (36.8%)
0.010, 0.919

15 (14.2%)
89 (84.0%)

17 (14.9%)
97 (85.1%)
12.160, 0.515

80 (75.5%)
3 (2.8%)
6 (5.7%)
6 (5.7%)

78 (68.4%)
4 (3.5%)
10 (8.8%)
9 (7.9%)

1 (0.9%)

2 (1.8%)
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Figure 1 presents the distribution of reasons for willingness or unwillingness to
participate in any clinical trial. Monetary compensation was the most common motivator for
clinical trial participation, and uncertainty of safety was the most common reason for nonparticipation in clinical trials.

32%
35%

Reasons for Acceptance

Reasons for Refusal

I am concerned about taking an experimental drug
12%

As I simply prefer not to

19%
48%
43%

I do not know if it would be safe
I do not want to be used as a guinea pig for
research

14%
15%
26%
20%

To help with my illness
13%

Might be an interesting thing

23%
26%
27%

To help future generations

53%
59%

If I get paid
0%
Active Treatment

10%

20%

30%

40%

50%

60%

70%

Placebo

Figure 1. Reasons for Acceptance/Refusal to Participate in Clinical Trials

About 68% of participants in both active and placebo groups thought that clinical
trials were performed at university medical centers. Similar percentage distributions were
noted in participants who felt that clinical trials were conducted in hospitals (41% vs. 53%),
clinics (38% vs. 39%), and private physicians’ offices (18% vs. 21%).
The majority of students (75% in active and 68% in placebo groups) preferred
learning from a physician regarding a clinical trial. In contrast, only 1% of active group
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respondents and 2% of placebo group respondents chose to learn from Facebook or other
social media (Table 2).
Impact of Demographics on Survey Response Results
Across all demographic comparisons, more than 75% of participants claimed to have
little or no knowledge at all, irrespective of age, gender, academic year, and college major.
However, with each increasing year of academic standing, there was a significant increase in
the number of participants who said they had some or little knowledge and a decrease in the
number of participants who said they had no knowledge of clinical research (p = .003). Also,
there was no statistical influence of age, gender, college year, or academic major on the
correctness of their answer to the definition of clinical trials. Across all subgroups, nearly
60% or more participants answered incorrectly.
Similarly, there was no statistically significant difference for readiness in clinical trial
participation among the demographic subgroups by age, gender, academic year, or college
major. However, with age, a slightly decreasing trend of those who might be willing to
participate was observed. Full information using separate tables for each survey question are
presented in Appendix F.
Responses Among Generation Y Participants
Within the pool of Generation Y participants, responses were compared between
active and placebo groups, and these results are presented in Table 3. The responses followed
a broadly similar trend, as the results of the whole population show no notable differences
between the active and placebo groups.
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Table 3
Difference in Survey Responses Between Active and Placebo Groups: Generation Y Participants

Knowledge Levels
Complete
Somewhat
Little
No knowledge at all
Correctness of Clinical
Trial Definition
Correct Response
Incorrect Response
Willingness to Participate
Yes
No
Willingness to
Administer a Novel
Treatment
Yes
No

Active group, n (%)

Placebo Group, n (%)

1 (1.1%)
20 (21.1%)
40 (42.1%)
34 (35.8%)

4 (3.8%)
21 (20.2%)
44 (42.3%)
35 (33.7%)

33 (34.7%)
62 (65.3%)

27 (26.0%)
77 (74.0%)

57 (60.0%)
37 (38.9%)

66 (63.5%)
38 (36.5%)

15 (16.0%)
79 (84.0%)

16 (15.4%)
88 (84.6%)

Also, Generation Y participant responses were separately compared with those of the
older participants (> 35-year-olds). These results are presented in the Figure 2. As compared
to older respondents, a higher percent of Generation Y respondents rated themselves as
having no knowledge of clinical research (34% vs. 18%), while fewer rated themselves as
having some (20% vs. 24%) or little knowledge (43% vs. 59%). More Generation Y
participants marked the definition of clinical trials or research incorrectly (70%) than older
participants (59%). However, 63% of Generation Y versus 47% of older participants
expressed interest in clinical trial participation, and 16% vs. 0% showed willingness to take a
novel medication. As the total number of older respondents is too low (n = 17), tests of
significance were not performed for the above comparisons.
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120%
100%
100%
84%
80%

70%
59%

59%

60%

43%
34%

40%
24%
20%

63%
47%

41%
31%

53%
37%

18%

20%

16%

3%0%

0

0%
Complete Somewhat

Little

No

Knowledge

Yes

No

Correctness of
Definition
18-34 Years

Yes

No

Willing to Participate

Yes

No

Willing to Take a
Novel Treatment

35 Years or Older

Figure 2. Generation Y Participant Responses (n = 199) vs. Older Participant (n = 17) Responses.
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Chapter 4: Discussion
This cross-sectional survey assessed knowledge and perceptions of clinical research
among students from the College of Arts and Sciences and the College of Technology at
Eastern Michigan University. Another researcher had conducted a similar survey in the
College of Business and College of Health and Human Services. These survey results were
published and available online (Pandiri, 2017). In both surveys, the same 12 questions were
posed, four related to demographics and eight assessing the participants’ understanding of
clinical trials and their willingness to participate in clinical trials. Except for the brief
explanation of clinical trials in the active intervention group and general paragraph in the
placebo group, there is no other difference between the survey sheets of the two groups.
In this study, it was observed that the active group (n = 106) provided no significantly
different answers with respect to knowledge or acceptance for participation in clinical trials
than the placebo group (n = 114). Although 66% of active and 69% of placebo participants
had rated themselves as having little to complete knowledge on clinical trials, 63% and 73%,
respectively, chose incorrect answers for clinical trial definition. This finding was similar to
those in the Pandiri (2017) study, which had 82.4% participants claiming little to complete
knowledge, of whom 61%–62% had given an incorrect definition. In our study, the majority
of active group respondents were aware that the definition of clinical research referred to
investigations performed in humans, but 46% of placebo group participants thought that it
related to laboratory studies, similar to the findings of Garapati (2015). These results indicate
that the intervention had a slight, although insignificant, impact on improving the
understanding of students. Had the intervention been more intense, coupled with detailed
description and perhaps a relevant exercise or an audio/video presentation on clinical trials
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before the survey, the difference likely would have reached significance in this study.
Consistent with this finding, the study by Pandiri (2017) also showed no significant
difference between the percentage of participants in active and placebo groups providing
correct answers.
In the subgroup analysis assessing the impact of demographics, participants in higher
grades showed a significantly higher level of knowledge (p = .003). But the percentages of
participants giving correct definitions did not increase with grade, similar to the study by
Garapati (2015). This clearly implies that participants overrated their knowledge levels.
Participants from the two colleges—Arts and Sciences, and Technology—indicated a similar
distribution of their level of knowledge. In the parallel study by Pandiri, significantly more
participants majoring in health and human services claimed to have more knowledge than
those majoring in business. In both studies, age did not significantly impact the students’
level of knowledge (Pandiri, 2017). In the present study, when age criteria were collapsed to
compare Generation Y (n = 199, 91%) to older participants (n = 17, 9%), more of the older
participants selected the correct definition of clinical trial.
Attitudes towards acceptance or reluctance to participate in a clinical trial were also
assessed. Sixty percent of active and 63% of placebo respondents stated willingness to
participate in a clinical trial; the difference between these groups was not significant. An
earlier study conducted in Maryland, which included more than 5,000 adults, found that
knowledge of clinical trials was a key factor that significantly increased the likelihood of
participation (Baquet, Commiskey, Daniel, & Mishra, 2006). However, knowledge acquired
during the period of illness or trial enrolment may not favor clinical trial participation
(Hoffner et al., 2012). Educating people much ahead of the decision-making point is
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necessary for enhancing participation rates (Profit, 2014). Thus, an insignificant difference
between active and placebo groups highlights the ineffectiveness of the brief description
provided in the active survey sheet in influencing the student’s decision for participation. A
similar finding was observed in the survey by Pandiri (2017), which showed that 53% of
active group participants vs. 59% of placebo group respondents might agree to participate in
clinical trials. This is well within the range of 29%–80% reported by other studies assessing
the willingness across varied non-patient populations (Ise, Takechi, Miyamoto, Ishizawa, &
Yanagawa, 2017; Fayed, 2016; Bruce et al., 2014; Bouida et al., 2016).
None of the demographics showed a significant impact on willingness to participate
in clinical trials. More Generation Y participants than older participants expressed this
willingness, but the survey included very few older participants. So extrapolation of these
results may not present a true picture. This was also a trend seen in the study by Pandiri
(2017) across the Colleges of Health and Human Services, and of Business at EMU.
More than half of the respondents in this survey indicated that the primary
motivational factor for trial participation was financial compensation. This was also
highlighted in a survey of healthcare professionals, 70% of whom considered financial
incentives as the key factor to encourage clinical trial participation (Fayed, 2016). Concerns
about safety were cited as the primary reason for non-participation, consistent with several
other studies (Fayed, 2016; Bouida et al., 2016; Dunlop et al., 2011; Profit, 2014).
A majority of survey participants chose to be informed of new clinical trials by their
physicians, and university medical centers were the most common clinical trial location.
Similar findings were observed in the research by Pandiri (2017) and Garapati (2015).

STUDENTS’ WILLINGNESS TO PARTICIPATE IN CLINICAL TRIALS

16

Overall the research results suggest that the intervention failed to demonstrate a
positive impact on knowledge and perceptions among the university students. There exists a
strong need for educational interventions that address knowledge and inculcate positive
attitudes towards clinical research (Brown et al., 2015). Future researchers may consider
investigating the effectiveness of intensive interventions, such as audio/video sessions or
more detailed description and a relevant exercise, among students.
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Chapter 5: Conclusion
The findings from this predominantly Generation Y participant sample revealed that
university students are generally unaware of clinical research. Also, providing a short
description of clinical research did not improve their knowledge or willingness to participate
in a clinical trial any more than those who were not given such information. In the future, the
effectiveness of intensive educational sessions involving audio/visual presentations or
exercises that ensure participants’ attention should be tested.
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Appendix C: Active Survey Sheet

Sc h ool of H ea l t h Sc ien c es

Please read this paragraph before you answer
Drug development is the process of bringing a new pharmaceutical or medicine to the market. For
pharmaceuticals/medicines to enter the market they have to be first tested in animals and humans.
Clinical research is research done with patients to determine the safety and effectiveness of a new
medicine. Please select the answer(s) that best represents your understanding. Check or
circle all that apply:

Q1. How knowledgeable are you about clinical
research?
a)
b)
c)
d)

Not at all knowledgeable
A little knowledgeable
Somewhat knowledgeable
Completely knowledgeable

Q2. Clinical research or clinical trials are:
a) Scientific investigations using humans to study
treatment of human disease
b) Scientific investigations using animals to study
treatment of human disease
c) Scientific investigations using laboratory studies
to study treatment of human disease
d) Not sure

Q3. If given a chance, would you consider
participating in a clinical research study?
a) Yes

b) No

Q4. I might agree to be in a clinical research study:
a)
b)
c)
d)

If I get paid
To help future generations
Because it might be an interesting thing to do
To get help with my illness

Q5. I might not agree to participate in a research
study:
a) Because I do not want to be used as a guinea pig
in research
b) Because I do not know if it would be safe
c) As I simply prefer not to
d) Because I am concerned about taking an
experimental drug

Q6. Would you take a drug which was not tested in
animal or humans?
a) Yes
b) No

Q7. How would you like to be informed of a
clinical research study you might be appropriate
for?
a)
b)
c)
d)
e)

From my physician
By reading an advertisement
From a government list
From an on campus posting
Through Facebook or other social media

Q8. Where do you think clinical research is
conducted? (Check or circle all that apply)
a)
b)
c)
d)
e)

Hospitals
University Medical Centers
Clinics
Private Physician's Office
Not sure

Q9. I am currently:
a) 18-24 years old
b) 25-34 years old
c) 35 or older

Q10. Female

Male

Prefer not to answer

Q11. My class year is:
a)
b)
c)
d)
e)

First
Second
Third
Fourth
Graduate

Q12. My major is or likely will be in the College of:
a)
b)
c)
d)
e)

Arts & Sciences
Technology
Health & Human Services
Business
Education
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Appendix D: Placebo Survey Sheet

Sc h oo l of H ea l t h Sc ien c es

Please read this paragraph before you answer
The scientific method is a body of techniques for investigating phenomena, acquiring new
knowledge, or correcting and integrating previous knowledge. To be termed scientific, a method
of inquiry is commonly based on empirical or measurable evidence subject to specific principles
of reasoning. Please select the answer(s) that best represents your understanding. Check or
circle all that apply:

Q1. How knowledgeable are you about clinical
research?
a)
b)
c)
d)

Not at all knowledgeable
A little knowledgeable
Somewhat knowledgeable
Completely knowledgeable

Q2. Clinical research or clinical trials are:
a) Scientific investigations using humans to study
treatment of human disease
b) Scientific investigations using animals to study
treatment of human disease
c) Scientific investigations using laboratory studies
to study treatment of human disease
d) Not sure

Q3. If given a chance, would you consider
participating in a clinical research study?
a) Yes

b) No

Q4. I might agree to be in a clinical research study:
a)
b)
c)
d)

If I get paid
To help future generations
Because it might be an interesting thing to do
To get help with my illness

Q5. I might not agree to participate in a research
study:
a) Because I do not want to be used as a guinea pig
in research
b) Because I do not know if it would be safe
c) As I simply prefer not to
d) Because I am concerned about taking an
experimental drug

Q6. Would you take a drug which was not tested in
animal or humans?
a) Yes
b) No

Q7. How would you like to be informed of a
clinical research study you might be appropriate
for?
a)
b)
c)
d)
e)

From my physician
By reading an advertisement
From a government list
From an on campus posting
Through Facebook or other social media

Q8. Where do you think clinical research is
conducted? (Check or circle all that apply)
a)
b)
c)
d)
e)

Hospitals
University Medical Centers
Clinics
Private Physician's Office
Not sure

Q9. I am currently:
a) 18-24 years old
b) 25-34 years old
c) 35 or older

Q10. Female

Male

Prefer not to answer

Q11. My class year is:
a)
b)
c)
d)
e)

First
Second
Third
Fourth
Graduate

Q12. My major is or likely will be in the College of:
a)
b)
c)
d)
e)

Arts & Sciences
Technology
Health & Human Services
Business
Education
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Appendix E: Verbal Consent Form

!
!
Informed Consent Form
The personnel in charge of this study are Divya Pandiri, the Principal Investigator and
Shashikiran Pathakamudi, the Co-Principal Investigator. They are graduate students at
Eastern Michigan University. Their faculty adviser is Irwin G. Martin. Throughout this
form, this person will be referred to as the “investigator.”

Purpose of the study
The purpose of this research study is to determine students understanding about health
research.
What will happen if I participate in this study?
Participation in this study involves answering questions related to research, which will
help us to determine college aged students understanding and their attitude towards
research.
What are the anticipated risks for participation?
There are no anticipated physical or psychological risks to participation.
The primary and the only risk of participation in this study is that the student sitting
beside or students among themselves might know they have participated in the study.
Since no names will be collected on the survey sheets there are no identifiers.
Are there any benefits to participating?
You will not directly benefit from participating in this research. You may tend to learn
more about Research.
What are the alternatives to participation?
The alternative is not to participate.
How will my information be kept confidential?
As we are not collecting student names on the survey sheets, your information will
therefore be confidential.
The investigators will also ask you not to tell anyone outside of the class about anything
that was said during the survey. However, we cannot guarantee that everyone will keep
the discussions private.
Approved by the Eastern Michigan University Human Subjects Review Committee
UHSRC Protocol Number: 871645-1
Study Approval Dates: 03/07/16 – 03/06/17

!
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Appendix F: Supplementary Tables
Supplementary Table 1
Impact of Demographics on the Knowledge on Clinical Trials
Factor
Age range
18-24 yrs
25-34 yrs
35 or older
Unspecified
Sex
Female
Male
Unspecified
College Year
First
Second
Third
Fourth
Graduate
College Major
Arts &
Sciences
Technology

Complete
Knowledge

Somewhat
Knowledge

A little
No Knowledge
Knowledge at All

χ2, p value
6.054, 0.734

3 (1.9%)
2 (4.5%)
0 (0.0%)
0 (0.0%)

32 (20.6%)
8 (18.2%)
4 (23.5%)
1 (33.3%)

69 (44.5%)
17 (38.6%)
10 (58.8%)
2 (66.7%)

51 (32.9%)
17 (38.6%)
3 (17.6%)
0 (0.0%)
1.326, 0.970

1 (1.3%)
4 (2.9%)
0

17 (21.8%)
28 (20.0%)
0

34 (43.6%)
63 (45.0%)
1 (50.0%)

26 (33.3%)
45 (32.1%)
1 (50.0%)
29.580, 0.003

0
0
0
4 (3.9%)
1 (50%)

4 (13.8%)
8 (20.0%)
10 (21.7%)
23 (22.3%)
0

11 (37.9%)
17 (42.5%)
21 (45.7%)
48 (46.6%)
1 (50%)

14 (48.3%)
15 (37.5%)
15 (32.6%)
28 (27.2%)
0

3 (2.7%)

23 (20.7%)

44 (39.6%)

41 (36.9%)

2 (1.8%)

22 (20.2%)

54 (49.5%)

31 (28.4%)

2.614, 0.455
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Supplementary Table 2
Impact of Demographics on the Correctness of Clinical Trials Definition
Factor
Age range
18-24 yrs
25-34 yrs
35 or older
Unspecified
Sex
Female
Male
Unspecified
College Year
First
Second
Third
Fourth
Graduate
College Major
Arts &
Sciences
Technology

Correct Response

Incorrect Response

49 (31.6%)
12 (27.3%)
7 (41.2%)
2 (66.7%)

106 (68.4%)
32 (72.7%)
10 (58.8%)
1 (33.1%)

χ2, p value
2.779, 0.427

1.043, 0.594
24 (30.8%)
46 (32.9%)
0

54 (69.2%)
94 (67.1%)
2 (100%)
4.416, 0.353

11 (37.9%)
8 (20.0%)
16 (34.8%)
35 (34.0%)
0

18 (62.1%)
32 (80.0%)
30 (65.2%)
68 (66.0%)
2 (100%)

31 (27.9%)

80 (72.1%)

39 (35.8%)

70 (64.2%)

1.563, 0.211
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Supplementary Table 3
Impact of Demographics on the Willingness to Participate in Clinical Trials
Factor
Age range
18-24 yrs
25-34 yrs
35 or older
Unspecified
Sex
Female
Male
Unspecified
College Year
First
Second
Third
Fourth
Graduate
College Major
Arts &
Sciences
Technology

Yes

No

101 (65.6%)
23 (52.3%)
8 (47.2%)
2 (66.7%)

53 (34.4%)
21 (47.7%)
9 (52.9%)
1 (33.3%)

χ2, p value
4.917, 0.241

5.456, 0.065
53 (68.8%)
82 (58.6%)
0

24 (31.2%)
58 (41.4%)
2 (100%)
3.463, 0.484

17 (60.7%)
26 (65.0%)
29 (63.0%)
63 (61.2%)
0

11 (39.3%)
14 (35.0%)
17 (37.0%)
40 (38.8%)
2 (100%)

69 (62.7%)

41 (37.3%)

66 (60.6%)

43 (39.4%)

0.110, 0.740
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